Anti-MOG antibodies are rare in patients with a first demyelinating flare suggestive of multiple sclerosis
Only 2.7% of the cohort analyzed had these antibodies, but they are very relevant for diagnosing and differentiating multiple sclerosis from the disease associated with anti-MOG antibodies (MOGAD).